Transvenous internal cardioversion for atrial fibrillation: A randomized comparison between catheters with different coil length

American Heart Journal

Volumn 144, Issue 5, 2002, Pages 851-857

  Boriani, Giuseppe ^a,b   Biffi, Mauro ^a,b   Camanini, Claudia ^a,b   Sammali, Antonio ^a,b   Bacchi, Letizia ^a,b   Accorti, Peter ^a,b   Luceri, Richard ^a,b   Zannoli, Romano ^a,b   Branzi, Angelo ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Rhythm Technologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY SINUS; DEFIBRILLATOR; ELECTRIC POTENTIAL; ELECTRIC SHOCK; ELECTRODE; ENERGY; FEMALE; HEART ATRIUM FIBRILLATION; HEART CATHETER; HUMAN; MALE; PAIN; PRIORITY JOURNAL; R WAVE;

EID: 0036850186     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2002.125506     Document Type: Article

References (39)

1. Cooper RAS, Alferness CA, Smith WM, et al. Internal cardioversion of atrial fibrillation in sheep. Circulation 1993;87:1673-86.
2. Ayers GM, Alferness CA, Ilina M, et al. Ventricular proarrhythmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation. Circulation 1994;89:413-22.
3. Murgatroyd FD, Slade AKB, Sopher SM, et al. Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. J Am Coll Cardiol 1995;25:1347-53.
4. Schmitt C, Alt E, Plewan A, et al. Low energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation. J Am Coll Cardiol 1996;28:994-9.
5. Levy S, Ricard P, Lau CP, et al. Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation. J Am Coll Cardiol 1997;29:750-5.
6. Boriani G, Biffi M, Bronzetti G, et al. Efficacy and tolerability in fully conscious patients of transvenous low energy internal atrial cardioversion for atrial fibrillation. Am J Cardiol 1998;81:241-4.
7. Ammer R, Alt E, Ayers G, et al. Pain threshold for low energy intracardiac cardioversion of atrial fibrillation with low or no sedation. Pacing Clin Electrophysiol 1997;20:230-6.
8. Boriani G, Biffi M, Camanini C, et al. Transvenous low energy internal cardioversion for atrial fibrillation: A review of clinical implications and future developments. Pacing Clin Electrophysiol 2001;24:99-107.
9. Santini M, Pandozi C, Toscano S, et al. Changes in intracardiac atrial cardioversion at rest and during exercise. J Am Coll Cardiol 1997;29:576-81.
10. Wellens HJJ, Lau CP, Luderitz B, et al. Atrioverter: An implantable device for the treatment of atrial fibrillation. Circulation 1998;98:1651-6.
11. Bailin S, Sulke N, Swerdlow CD. Clinical experience with a dual chamber implantable cardioverter defibrillator in patients with atrial fibrillation and flutter [abstract]. Pacing Clin Electrophysiol 1999;22:871.
12. Albers G, Dalen J, Laupacis A, et al. Antithrombotic therapy in atrial fibrillation. Chest 2001;119:194-206S
13. Luceri RM, Accorti PR. Temporary transvenous cardioversion and defibrillation: A new method for practical tachyarrhythmia management. Pacing Clin Electrophysiol 1997;20:168-72.
14. Boriani G, Biffi M, Capucci A, et al. Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation. J Am Coll Cardiol 1999;33:333-41.
15. Santini M, Pandozi C, Altamura G, et al. Single shock endocavitary low energy intracardiac atrial cardioversion of chronic atrial fibrillation. J Interv Cardiac Electrophysiol 1999;3:45-51.
16. Kalman JM, Power JM, Chen J, et al. Importance of electrode design, lead configuration and impedance for successful low energy transcatheter atrial defibrillation in dogs. J Am Coll Cardiol 1993;22:1199-206.
17. Tacker WA, Schoenlein WE, Janas W, et al. Catheter electrode evaluation for transvenous atrial defibrillation [abstract]. Pacing Clin Electrophysiol 1993;16:853.
18. Gonzales X, Wagner DO, Muff DM, et al. Reduced atrial fibrillation by increasing coil length in a single-pass lead [abstract]. Pacing Clin Electrophysiol 1997;20:1149.
19. Hillsey RE, Yarger MD, Greenfield RA, et al. Effect of catheter electrode length on internal atrial defibrillation threshold in humans [abstract]. Circulation 1995;92(1 Suppl):1-471-2.
20. Timmenrmans C, Rodriguez L-M, Ayers GM, et al. Effect of electrode length on atrial defibrillation thresholds. J Cardiovasc Electrophysiol 1998;9:582-7.
21. Heisel A, Jung J. The atrial defibrillator: A stand alone device or part of a combined dual-chamber system? Am J Cardiol 1999;83:218-26D.
22. Jung W, Wolpert C, Esmailzadek B, et al. Clinical experience with implantable atrial and combined atrioventricular defibrillators. J Interv Card Electrophysiol 2000;4:185-95.
23. Ayers GM. New concepts in atrial defibrillation. J Interv Card Electrophysiol 2000;4:155-61.
24. Tse HF, Lau CP, Yomtov BM, et al. Implantable atrial defibrillator with a single-pass dual-electrode lead. J Am Coll Cardiol 1999;33:1974-80.
25. Lok NS, Lau CP, Tse HF, et al. Clinical shock tolerabilily and effect of different right atrial electrode locations on efficacy of low energy human transvenous atrial defibrillation using an implantable lead system. J Am Coll Cardiol 1997;30:1324-30.
26. Tommassoni G, Newby KH, Kearney MM, et al. Testing different biphasic waveforms and capacitances: Effect on atrial defibrillation threshold and pain perception. J Am Coll Cardiol 1996;28:695-9.
27. Harbinson MT, Allen JD, Imam Z, et al. Rounded biphasic waveform reduces energy requirements for transvenous catheter cardioversion of atrial fibrillation and flutter. Pacing Clin Electrophysiol 1997;20:226-9.
28. Cooper RAS, Johnson EE, Wharton JM. Internal atrial defibrillation in humans: The improved efficacy of biphasic waveforms and the importance of phase duration. Circulation 1997;95:1487-96.
29. Cooper RAS, Plumb VJ, Epstein AE, et al. Marked reduction in internal atrial defibrillation thresholds with dual-current pathways and sequential shocks in humans. Circulation 1998;97:2527-35.
30. Boriani G, Biffi M, Zannoli R, et al. Transvenous internal cardioversion for atrial fibrillation: A randomized study on defibrillation threshold and tolerabilily of asymmetrical compared with symmetrical shocks. Int J Cardiol 1999;71:63-9.
31. Jung W, Tebbenjohanns J, Wopert C, et al. Safely, efficacy and pain perception of internal defibrillation in humans [abstract]. Circulation 1995;92(1 Suppl):1-472.
32. Steinhaus DM, Cardinal D, Mongeon L, et al. Atrial defibrillation: Are low energy shocks acceptable to patients? [abstract]. Pacing Clin Electrophysiol 1996;19:625.
33. Jung W, Pfeiffer D, Wolpert C, et al. Which patients do benefit from an implantable atrial defibrillator? [abstract]. J Am Coll Cardiol 1996;27:301.
34. Heisel A, Jung J, Schubert B, et al. Internal atrial defibrillation by using a new single atrial lead system and evaluation of two new biphasic waveforms. In: Antonioli GE, editor. Pacemaker Leads 1997. Bologna: Monduzzi; 1997. p. 567-72.
35. Keane D. Impact of pulse characteristics on atrial defibrillation energy requirements. Pacing Clin Electrophysiol 1994;17:1048-57.
36. Boriani G, Biffi M, Martignani C, et al. Current clinical perspectives on implantable devices for atrial defibrillation. Curr Opin Cardiol 2002;17:82-9.
37. Lok NS, Lau CP, Tang YW. Variation of defibrillation threshold in repeated transvenous atrial defibrillation [abstract]. Pacing Clin Electrophysiol 1995;18:850.
38. Lau CP, Lok NS. A comparison of transvenous atrial defibrillation of acute and chronic atrial fibrillation and the effect of intravenous sotalol on human atrial defibrillation threshold. Pacing Clin Electrophysiol 1997;20:2442-52.
39. Boriani G, Bartolini P, Biffi M, et al. Atrial spinal analysis and defibrillation threshold assessment in chronic persistent and reinduced atrial fibrillation. J Cardiovasc Electrophysiol 2002;13:449-54.